HIV Clinical Trial Hailed by California Stem Cell Agency
The California stem cell agency today scored what it called an “important milestone” with the announcement of the start of a clinical trial involving a therapy to help protect persons infected with HIV from the effects of the virus.
The trial is partially funded from a $20 million award from the stem cell agency, which is known as CIRM, to researchers at
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.